References
- Maraha B, Bonten H, van Hooff H, Fiolet H, Buiting AG, Stobberingh EE. Infectious complications and antibiotic use in renal transplant recipients during a 1-year follow-up. Clin Microbiol Infect 2001;7:619–25.
- Esezobor CI, Nourse P, Gajjar P. Urinary tract infection following kidney transplantation: frequency, risk factors and graft function. Pediatr Nephrol 2012;27:651–7.
- Fox BC, Sollinger HW, Belzer FO, Maki DG. A prospective, randomized, double-blind study of trimethoprim- sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprim-sulfamethoxazole, effects on the microflora, and the cost-benefit of prophylaxis. Am J Med 1990;89:255–74.
- Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transplant 2005;19:230–5.
- Dupont PJ, Psimenou E, Lord R, Buscombe JR, Hilson AJ, Sweny P. Late recurrent urinary tract infections may produce renal allograft scarring even in the absence of symptoms or vesicoureteric reflux. Transplantation 2007;84:351–5.
- Song JC, Hwang HS, Yoon HE, Kim JC, Choi BS, Kim YS, et al. Endoscopic subureteral polydimethylsiloxane injection and prevention of recurrent acute graft pyelonephritis. Nephron Clin Pract 2011;117:c385–9.
- Paterson DL, Bonomo RA. Extended-spectrum beta- lactamases: a clinical update. Clin Microbiol Rev 2005; 18:657–86.
- Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob. Agents Chemother 2010;54: 5099–104.
- Brown PD. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep 2002;4:525–8.
- European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints, version 01/01/2014. http://www.eucast.org [Internet]. [cited 2014 31]. Available from: about:newtab
- Linares L, García-Goez JF, Cervera C, Almela M, Sanclemente G, Cofán F, et al. Early bacteremia after solid organ transplantation. Transplant Proc 2009;41:2262–4.
- Pinheiro HS, Mituiassu AM, Carminatti M, Braga AM, Bastos MG. Urinary tract infection caused by extended- spectrum beta-lactamase-producing bacteria in kidney transplant patients. Transplant Proc 2010;42:486–7.
- Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El-Amm JM, et al. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant 2006;20:401–9.
- Silva C, Afonso N, Macário F, Alves R, Mota A. Recurrent urinary tract infections in kidney transplant recipients. Transplant Proc 2013;45:1092–5.
- Lim J-H, Cho J-H, Lee J-H, Park Y-J, Jin S, Park G-Y, et al. Risk factors for recurrent urinary tract infection in kidney transplant recipients. Transplant Proc 2013;45:1584–9.
- Lyerová L, Lácha J, Skibová J, Teplan V, Vítko S, Schück O. Urinary tract infection in patients with urological complications after renal transplantation with respect to long-term function and allograft survival. Ann Transplant 2001;6:19–20.
- Abbott KC, Swanson SJ, Richter ER, Bohen EM, Agodoa LY, Peters TG, et al. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis 2004;44:353–62.
- Müller V, Becker G, Delfs M, Albrecht KH, Philipp T, Heemann U. Do urinary tract infections trigger chronic kidney transplant rejection in man? J Urol 1998;159:1826–9.
- Rafat C, Vimont S, Ancel PY, Xu-Dubois YC, Mesnard L, Ouali N, et al. Ofloxacin: new applications for the prevention of urinary tract infections in renal graft recipients. Transpl Infect Dis 2011;13:344–52.
- Hoban DJ, Nicolle LE, Hawser S, Bouchillon S, Badal R. Antimicrobial susceptibility of global inpatient urinary tract isolates of Escherichia coli: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program: 2009-2010. Diagn Microbiol Infect Dis 2011;70:507–11.